Previous 10 | Next 10 |
Synthorx (NASDAQ: THOR ) +169% on being acquired by Sanofi. More news on: Synthorx, Inc., XBiotech Inc., ArQule, Inc., Stocks on the move, Read more ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . U.S. stock index futures are suggesting a pause from Friday's job-fueled rally as investors prepare for a series of major risk ev...
Bolstering its immuno-oncology pipeline, Sanofi (NASDAQ: SNY ) will acquire all of the outstanding shares of Synthorx (NASDAQ: THOR ) for $68 per share in cash, representing a 172% premium to the latter's closing price on Dec. 6. More news on: Sanofi, Synthorx, Inc., Healthcare stocks ne...
SAN DIEGO, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today announced the Company will present at multiple upcoming investor conferences: Live webcasts of t...
Synthorx (NASDAQ: THOR ): Q3 GAAP EPS of -$0.38 beats by $0.12 . More news on: Synthorx, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today reported financial results and provided a business update for the third quarter ended September 30,...
SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today announced that preclinical data highlighting THOR-809 will be presented at the American College of ...
SAN DIEGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today announced the presentation of three posters at the upcoming Society for Immunotherapy of Canc...
Investors are optimistic heading into Winnebago 's (NYSE: WGO) fourth-quarter earnings report. The leading recreational vehicle manufacturer is sure to announce its first annual sales decline in years as the RV industry contracts following a nine-year record run. However, Winnebago's operatin...
SAN DIEGO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today announced that preclinical data for immuno-oncology product candidate, THOR-707, will be presented...
News, Short Squeeze, Breakout and More Instantly...
AMC Theatres (NYSE: AMC) has reported domestic and global success on its busiest weekend of 2022 so far from Thursday July 7th through Sunday July 10th. This was led by the opening weekend of Thor: Love and Thunder as the box office was propelled by several summer blockb...
Thor Industries (NYSE: THOR ) , a recreational vehicle maker, reported better-than-expected quarterly earnings Wednesday amid high demand for its products. The manufacturer reported earnings of USD6.32 per share, compared to the expected USD...
Nigeria is known as one of Africa’s largest and oldest oil and natural gas producers – the sector accounts for more than 90% of the country’s exports, and 80% of the federal government’s revenue. But until recently, the mining sector has been on the...